ADORACION CHAO: Open Payments
NPI 1104104462 · NEW MILFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 8 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $1,190 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $353 |
| Vanda Pharmaceuticals Inc. | 2 | $247 |
| ABBVIE INC. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
Products named: FANAPT, BREZTRI, VRAYLAR, Biktarvy, AIRSUPRA, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
